Medicine Recommendations

LSCMMG

Green

BwD

Pending

Green

Pending

Pending

Green

Pending

Pending

Pending

Methylprednisolone (injection)

Date Posted: 01 - Jan - 2016

BNF chapter: Endocrine system

Expand/Collapse

Acute Gout (as per LSCMMG Guidelines)

Black

Black

Black

Black

Black

Black

Black

Black

Black

Nephrotrans 500mg gastro-resistant capsules (sodium hydrogen carbonate)

Date Posted: 31 - Aug - 2023

BNF chapter: Endocrine system

Expand/Collapse

Metabolic acidosis and for maintenance treatment against recurrence of metabolic acidosis in adults with chronic renal impairment.

Red

Pending

Red

Red

Pending

Red

Red

Red

Pending

Pamidronate disodium

Date Posted: 01 - Oct - 2014

BNF chapter: Endocrine system

Expand/Collapse

Pagets Disease

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

Green

Green

Green

Green

Green

Green

Green

Green

Green

Pioglitazone

Date Posted: 01 - Feb - 2018

BNF chapter: Endocrine system

Expand/Collapse

Type 2 diabetes

Green

Pending

Green

Pending

Pending

Green

Pending

Pending

Pending

Prednisolone

Date Posted: 01 - Jan - 2016

BNF chapter: Endocrine system

Expand/Collapse

Acute Gout (as per LSCMMG Guidelines)

Green

Green

Green

Green

Green

Green

Green

Green

Green

Progesterone capsules

Date Posted: 13 - Sep - 2021

BNF chapter: Endocrine system

Expand/Collapse

Progestogenic opposition of oestrogen HRT in women with an intact uterus

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Quinagolide

Date Posted: 05 - Jun - 2024

BNF chapter: Endocrine system

Hyperprolactinaemia

Black

Black

Black

Black

Black

Black

Black

Black

Black

Raloxifene

Date Posted: 01 - May - 2013

BNF chapter: Endocrine system

Expand/Collapse

Primary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA160)

NICE TA160 - Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended)

Green

Pending

Green

Green

Pending

Green

Green

Green

Pending

Raloxifene

Date Posted: 01 - Mar - 2015

BNF chapter: Endocrine system

Expand/Collapse

Secondary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA161)

NICE TA161 Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Relugolix–estradiol–norethisterone acetate

Date Posted: 24 - Jan - 2023

BNF chapter: Endocrine system

Expand/Collapse

Moderate to severe symptoms of uterine fibroids (NICE TA832)

NICE TA832 - Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids

Green

Green

Green

Green

Green

Green

Green

Green

Green

Risedronate sodium

Date Posted: 01 - Sep - 2017

BNF chapter: Endocrine system

Expand/Collapse

Osteoporosis (NICE TA464)

NICE TA464 - Bisphosphonates for treating osteoporosis

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

Red

Red

Red

Red

Red

Red

Red

Red

Red

Romosozumab

Date Posted: 15 - Jul - 2022

BNF chapter: Endocrine system

Expand/Collapse

Severe osteoporosis (NICE TA791)

NICE TA791 - Romosozumab for treating severe osteoporosis

Red

Red

Red

Red

Red

Red

Red

Red

Red

Roxadustat

Date Posted: 14 - Sep - 2022

BNF chapter: Endocrine system

Expand/Collapse

Treating symptomatic anaemia in chronic kidney disease - NICE TA807

NICE TA807 - Roxadustat for treating symptomatic anaemia in chronic kidney disease

Green

Green

Green

Green

Green

Green

Green

Green

Green

Semaglutide

Date Posted: 01 - Sep - 2018

BNF chapter: Endocrine system

Expand/Collapse

Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; or in addition to other medicinal products for the treatment of diabetes.

NICE NG28 - Type 2 diabetes in adults: management

Red

Red

Red

Red

Red

Red

Red

Red

Red

Semaglutide (Wegovy)

Date Posted: 27 - Apr - 2023

BNF chapter: Endocrine system

Expand/Collapse

Managing overweight and obesity (NICE TA875)

NICE TA 875 - Semaglutide for managing overweight and obesity

LSCMMG

Green (R)(Restricted)

BwD

Green (R)(Restricted)

BP

Green (R)(Restricted)

CSR

Green (R)(Restricted)

EL

Green (R)(Restricted)

FW

Green (R)(Restricted)

GP

Green (R)(Restricted)

MB

Green (R)(Restricted)

WL

Green (R)(Restricted)

Semaglutide Tablets

Date Posted: 18 - Aug - 2020

BNF chapter: Endocrine system

Expand/Collapse

For the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise.

Green

Green

Green

Green

Green

Green

Green

Green

Green

Sitagliptin

Date Posted: 01 - Feb - 2018

BNF chapter: Endocrine system

Expand/Collapse

Type 2 diabetes

Red

Red

Red

Red

Red

Red

Red

Red

Red

Somatrogon

Date Posted: 17 - Mar - 2023

BNF chapter: Endocrine system

Expand/Collapse

Treating growth disturbance in children and young people aged 3 years and over (NICE TA863)

NICE TA863 - Somatrogon for treating growth disturbance in children and young people aged 3 years and over

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Somatropin

Date Posted: 01 - May - 2013

BNF chapter: Endocrine system

Expand/Collapse

Adult growth hormone deficiency (NICE TA64) & Growth failure in children (NICE TA188)

NICE TA64 - Human growth hormone (somatropin) in adults with growth hormone deficiency

NICE TA188 - Human growth hormone (somatropin) for the treatment of growth failure in children

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Sotagliflozin with insulin

Date Posted: 14 - Jul - 2020

BNF chapter: Endocrine system

Expand/Collapse

Breadcrumb

Medicine Recommendations

Acute Gout (as per LSCMMG Guidelines)

Pagets Disease

Type 2 diabetes

Acute Gout (as per LSCMMG Guidelines)

Primary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA160)

Secondary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA161)

Osteoporosis (NICE TA464)

Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; or in addition to other medicinal products for the treatment of diabetes.

For the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise.

Type 2 diabetes

Adult growth hormone deficiency (NICE TA64) & Growth failure in children (NICE TA188)